CNR Institutional Research Information System

BONOMI, SERENA

BONOMI, SERENA  

Istituto di Genetica Molecolare "Luigi Luca Cavalli Sforza"  

Mostra records
Risultati 1 - 13 di 13 (tempo di esecuzione: 0.026 secondi).
Titolo Data di pubblicazione Autore(i) File
Band gap tuning through cation and halide alloying in mechanochemically synthesized Cs3(Sb1−xBix)2Br9 and Cs3Sb2(I1−xBrx)9 solid solutions 1-gen-2023 Giovilli, G.; Albini, B.; Grisci, V.; Bonomi, S.; Moroni, M.; Mosconi, E.; Kaiser, W.; De Angelis, F.; Galinetto, P.; Malavasi, L.
HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition. 1-gen-2013 Bonomi S; di Matteo A; Buratti E; Cabianca DS; Baralle FE; Ghigna C; Biamonti G.
Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy. 1-gen-2013 Bonomi, S; Gallo, S; Catillo, M; Pignataro, D; Biamonti, G; Ghigna, C
Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in Cancer. 1-gen-2013 Siegfried, Z; Bonomi, S; Ghigna, C; Karni, R
Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in Cancer. 1-gen-2013 Zahava Siegfried; Serena Bonomi; Claudia Ghigna;Rotem Karni
Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT). 1-gen-2012 Biamonti Giuseppe; Bonomi Serena; Gallo Stefania; Ghigna Chigna
Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT). 1-gen-2012 Biamonti, G; Bonomi, S; Gallo, S; Ghigna, C
Pro-metastatic splicing of Ron proto-oncogene mRNA can be reversed: Therapeutic potential of bifunctional oligonucleotides and indole derivatives 1-gen-2010 Ghigna C; De Toledo M; Bonomi S; Valacca C; Gallo S; Apicella M Eperon I; Taz Ji; Biamonti G
Regulation of splicing factor SF2/ASF in response to proliferation, differentiation and DNA damage 1-gen-2010 Montecucco A; Ghigna C; Leva V; Bonomi S; Soza S; Biamonti G
Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene. 1-gen-2010 Valacca C; Bonomi S; Buratti E; Pedrotti S; Baralle FE; Sette C; Ghigna C; Biamonti G.
Splicing Factor SF2/ASF at the crossroad between cell proliferation, differentiation and the DNA damage response. 1-gen-2010 Montecucco A; Ghigna C; Leva V; Bonomi S; Soza S; Biamonti G
The complex connection between alternative splicing and the epithelial to mesenchymal cell transition 1-gen-2010 Ghigna C; Soza S; Bonomi S; Hollander D; BenDov C; Valcarcel J; Ast G; Biamonti G.
Sam68 regulates epithelial to mesenchymal transition through alternative splicing- activated NMD of the SF2/ASF proto-oncogene. 1-gen-2009 Valacca, C; Bonomi, S; Buratti, E; Baralle, F; Ghigna, C; Biamonti, G